◄ back to all posts
Financial data and stock pages provided by
Fintel.io
◄ back to all posts
MRKR: Marker Therapeutics Inc Stock
Written by | Jul 6, 2018SIC 2834 – Pharmaceutical Preparations
Valuation | |
---|---|
Market Cap ($M) | 170.18 |
Enterprise Value ($M) | 154.59 |
Book Value ($M) | 27.34 |
Book Value / Share | 0.33 |
Price / Book | 6.44 |
NCAV ($M) | 6.14 |
NCAV / Share | 0.07 |
Price / NCAV | 28.25 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | -1.05 |
Return on Assets (ROA) | -0.62 |
Return on Equity (ROE) | -0.65 |
Liquidity (mrq) | |
---|---|
Quick Ratio | n/a |
Current Ratio | 3.81 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 24.41 |
Assets | 45.61 |
Liabilities | 18.27 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 0.00 |
Operating Income | -28.89 |
Net Income | -28.71 |
Earnings Per Share Basic And Diluted | -0.61 |
Earnings Per Share Diluted | -0.61 |
Earnings Per Share Basic | -0.61 |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | -18.86 |
Cash from Investing | -10.43 |
Cash from Financing | -10.43 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13D/A | New Enterprise Associates 16, L.P. | 17.40 | 65.31 | |
13D/A | Leen Ann M. | 2.89 | 0.00 | |
13D/A | Eastern Capital LTD | 5.00 | -11.19 | |
13G/A | Perceptive Advisors Llc | 0.00 | -100.00 | |
13D | Wilson John Robert | 17.37 | ||
13D | Vera Juan | 5.90 | ||
13G/A | Brio Capital Master Fund Ltd. | 0.05 | ||
13D | Aisling Capital IV, LP | 7.70 | ||
13D | Iroquois Capital Management, LLC | 7.30 | -4.14 | |
13G/A | American Capital Management LLC | 4.90 | 100.00 | |
13G/A | Empery Asset Management, LP | 4.99 | ||
13G/A | Tonaquint, Inc. | 9.99 | ||
13G/A | Centra Holdings, Inc. | 9.90 | ||
13D | Barchha Sailesh C. | 7.58 | ||
13D | Gardner Michael | 7.58 | ||
13G/A | Ironridge Global IV, Ltd. |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
File Date | Form | SEC Filings |
---|---|---|
Annual Report – 10-K | ||
Quarterly Report – FORM 10-Q | ||
Quarterly Report – 10-Q | ||
Quarterly Report – FORM 10-Q | ||
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
337,916 | 1,679,200 | 20.12 | |
209,652 | 1,198,706 | 17.49 | |
389,304 | 2,252,350 | 17.28 | |
141,943 | 1,159,695 | 12.24 | |
(click for more detail) |
|||
(click for list of largest short owners) |
Similar Companies | |
---|---|
MOR – MorphoSys AG | MORF – Morphic Holding Inc |
MREO – Mereo BioPharma Group plc | MRNA – Moderna Inc |
MRNS – Marinus Pharmaceuticals Inc |
Financial data and stock pages provided by
Fintel.io
2018/07/06